CAJ | 학술논문

构建包括技术创新资源投入能力、技术创新产出能力、技术创新潜力和技术创新环境的技术创新能力评价指标体系，运用熵权法确定各指标权重，建立我国医药制造业技术创新能力线性加权综合评价模型。以2009～2012年我国内地29个省市自治区的面板数据为基础，对各地区医药制造业的技术创新能力进行综合评价，结果表明我国不同省市自治区的技术创新能力存在显著差异。根据综合评价得分及排序，将我国29个省市区分为4种类型，对各型省市自治区进行分析，并提出提升技术创新能力的对策建议。
구건포괄기술창신자원투입능력、기술창신산출능력、기술창신잠력화기술창신배경적기술창신능력평개지표체계，운용적권법학정각지표권중，건립아국의약제조업기술창신능력선성가권종합평개모형。이2009～2012년아국내지29개성시자치구적면판수거위기출，대각지구의약제조업적기술창신능력진행종합평개，결과표명아국불동성시자치구적기술창신능력존재현저차이。근거종합평개득분급배서，장아국29개성시구분위4충류형，대각형성시자치구진행분석，병제출제승기술창신능력적대책건의。
This paper establishes an evaluation index system for technological innovation resources input capability, technological inno-vation output capacity, technological innovation potentiality and technological innovation environment of Chinese pharmaceutical industry. Taking use of entropy method, the weight of each index can be determined and a linear-weighted comprehensive evaluation model is estab-lished to assess technological innovation capability of pharmaceutical industry in China.It takes 2009~2012 panel data of 29 provinces and autonomous regions in China as basis and makes a comprehensive evaluation of the technological innovation capability of each region.The result shows that significant differences exist among these regions in technological innovation capability.According to the comprehensive e-valuation score and ranking, 29 provinces and autonomous regions were divided into 4 types.Based on the analysis of each type, corre-sponding suggestions were provided for the provinces and autonomous regions to improve their technological innovation capability.